WASHINGTON, DC –  The American Pharmacists Association (APhA) Foundation Board of Directors recently unanimously voted to appoint the current senior vice president of research and innovation of the APhA Foundation as the foundation’s executive director.

WASHINGTON, D.C.—The American Pharmacists Association (APhA) issued the following statement applauding the FTC’s announcement of a 5-0 vote to initiate a 6(b) study “to scrutinize the impact of vertically integrated pharmacy benefit managers on the access and affordability of prescription drugs.”

The Board of Trustees of the American Pharmacists Association announced today that Ilisa Bernstein, PharmD, JD, FAPhA, has been named Interim CEO, effective immediately. Bernstein’s appointment follows the departure of Scott Knoer, PharmD, MS, as Executive Vice-President and CEO.